GURUFOCUS.COM » STOCK LIST » USA » NAS » Lantheus Holdings Inc (NAS:LNTH) » Definitions » GF Value Rank
Switch to:

Lantheus Holdings GF Value Rank

: 1 (As of Today)
View and export this data going back to 2015. Start your Free Trial

Lantheus Holdings has the GF Value Rank of 1.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Lantheus Holdings GF Value Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's GF Value Rank falls into.



Lantheus Holdings GF Value Rank Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings Business Description

Lantheus Holdings logo
Traded in Other Exchanges
Address
331 Treble Cove Road, North Billerica, MA, USA, 01862
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.
Executives
Baylor-henry Minnie director C/O SCPHARMACUETICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Yao Ying Vivian officer: Chief Human Resources Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Sabens Andrea officer: Chief Accounting Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Walker Carol officer: Senior Vice President, Quality C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Montagut Etienne officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Niedzwiecki Daniel officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Maeusli Heinz Christoph director SCHUETZENWEG 3 ENGELBURG V8 9032
Ber Gerard director C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Blanchfield Paul officer: Chief Commercial Officer C/O LANTHEUS HOLDINGS, INC. 331 NORTH BILLERICA MA 01862
Molnar Istvan officer: Chief Medical Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Marshall Robert J. Jr. officer: CFO and Treasurer C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Bolla John J. director C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Pucel Kenneth director 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Thrall James H director 343 COMMERCIAL STREET #314 BOSTON MA 02109
Pruden Gary J director ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Lantheus Holdings Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)